![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/17 | |
A61P 27/02 | |||
A61P 11/06 | |||
A61P 17/06 | |||
A61P 19/02 |
(11) | Number of the document | 1802325 |
(13) | Kind of document | T |
(96) | European patent application number | 05838191.4 |
Date of filing the European patent application | 2005-10-12 | |
(97) | Date of publication of the European application | 2007-07-04 |
(45) | Date of publication and mention of the grant of the patent | 2015-02-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2005/037114 |
Date | 2005-10-12 |
(87) | Number | WO 2006/042329 |
Date | 2006-04-20 |
(30) | Number | Date | Country code |
964263 | 2004-10-12 | US | |
159919 | 2005-06-22 | US |
(72) |
ASHKENAZI, Avi, US
HELMY, Karim Yussef, US
FONG, Sherman, US
GODDARD, Audrey, US
GURNEY, Austin, L., US
KATSCHKE, Jr., Kenneth James, US
LOOKEREN, Menno, Van, US
WOOD, William, I., US
|
(73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080-4990,
US
|
(54) | CRIG POLYPEPTIDE FOR PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED DISORDERS |
CRIG POLYPEPTIDE FOR PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED DISORDERS |